Home > Financial Ratios > ORCHID PHARMA

ORCHID PHARMA
EV/EBIT

    Back to All Ratios
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 35.6147.5621.21-60.59-243.82

What is the latest EV/EBIT ratio of ORCHID PHARMA ?

The latest EV/EBIT ratio of ORCHID PHARMA is 35.61 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202535.61
Mar202447.56
Mar202321.21
Mar2022-60.59
Mar2021-243.82

How is EV/EBIT of ORCHID PHARMA Trending?

Years EV/EBIT % Change
Mar2025 35.61
-25.13
Mar2024 47.56
124.23
Mar2023 21.21
Positive
Mar2022 -60.59
Negative
Mar2021 -243.82 -

Other Financial Ratios of ORCHID PHARMA


Compare EV/EBIT ratio of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹5,820.8 Cr -0.5% -1.4% 37% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹456,114.0 Cr NA -3.9% 17.3% Stock Analytics
DIVIS LABORATORIES ₹239,321.0 Cr 5% 21.5% 44.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹185,924.0 Cr -2.1% -0.2% 34.3% Stock Analytics
CIPLA ₹113,778.0 Cr -2% -2.5% -8.1% Stock Analytics
DR REDDYS LABORATORIES ₹99,025.9 Cr 0.4% 4.5% -4.4% Stock Analytics


ORCHID PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-0.5%

-1.4%

37%

SENSEX

0.7%

0.8%

-5.1%


You may also like the below Video Courses